Form 8-K - Current report:
SEC Accession No. 0001104659-20-004815
Filing Date
2020-01-16
Accepted
2020-01-16 17:21:04
Documents
1
Period of Report
2020-01-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203657-1_8k.htm 8-K 16016
  Complete submission text file 0001104659-20-004815.txt   17136
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 20531769
SIC: 2836 Biological Products, (No Diagnostic Substances)